Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

Abstract

These findings highlight the ability of ARG2-specific T cells to modulate the immunosuppressive TME and suggest that ARG2-based immunomodulatory vaccines may be an interesting option for cancer immunotherapy.